In December, the technology-driven startup investment market was active, with many companies securing funding. Inito expanded its hormone analysis platform, Assaia optimized airport operations, Aether Bio developed new proteins, Wearlinq enhanced ECG monitoring, and Built AI automated real estate analysis. Their successes demonstrate the potential of technology applications across multiple fields.

Author: a16z New Media Edited by: Block unicorn As investors, our responsibility is to gain in-depth insight into every corner of the technology industry to grasp future development trends. Therefore, every December, we invite investment teams to share a major concept they believe technology companies will need to address in the coming year. Today, we will share perspectives from the Infrastructure, Growth, Bio + Health, and Speedrun teams. Stay tuned for other team shares tomorrow. Infrastructure Jennifer Li: How Startups Navigate the Chaos of Multimodal Data Unstructured, multimodal data has always been the biggest bottleneck faced by companies, as well as their greatest untapped treasure. Every company is immersed in a sea of PDFs, screenshots, videos, logs, emails, and semi-structured data.

At the forefront of today's technology, biotech cryptocurrencies are stirring up an unprecedented revolution. Through biotech blockchain applications, scientists and investors are finally able to break through traditional boundaries and collaboratively explore innovations in biomedical blockchain. This article will delve into the potential of bioinformatics cryptocurrency investments and how biotechnology tokenomics are reshaping the model of global scientific collaboration. Blockchain solutions for biosciences are rapidly evolving, poised to reveal their immense value. The Spectacular Collision of Biotechnology and Blockchain: BIO Token Leads the DeSci Wave The BIO Protocol represents the deep integration of biotechnology and blockchain technology, reshaping the innovation ecosystem of the traditional biomedical sector through the decentralized science (DeSci) model. In November 2024, BIO Protocol completed a community fundraising round of $30.3 million, a funding scale that fully reflects global capital’s confidence in biotech blockchain.

Bio Protocol announced that its token BIO is now live on BNB Chain and can be traded on PancakeSwap. In addition, more DeSci tokens will be launched to provide builders and the research community with full-stack solutions, accelerating scientific progress. Future plans include features such as a DeSci bridge, staking, and a Launchpad.

According to Mars Finance news on November 20, per the Bio Protocol announcement, BioXP Season 2 is now live. Users need to stake BIO to generate veBIO in order to obtain ecological token staking XP and airdrop eligibility. The new mechanism includes: 1) veBIO level multiplier, up to 10 times XP earnings; 2) New tokens staked for the first 60 days enjoy XP bonuses; 3) veBIO holders will automatically receive new ecological token airdrops. All old BioXP will expire after the second ignition sale.

YZi Labs announced its first biotech investment on November 11, with an investment in regenerative medicine company Renewal Bio, which generates matching human cells from patient cells through the Stembroid™ platform, aiming to address organ shortages. The company was founded in 2022 by Professor Jacob Hanna of the Weizmann Institute of Science, and the funding will accelerate preclinical development of stem cells.

Upbit's listing of BIO Protocol's token led to a 58% price surge, sparking a trading volume increase over 532%. This event also positively impacted the Decentralized Science market, highlighting Upbit's influence on altcoin movements.

Key Notes BIO surges over 37.5% in 24 hours amid Upbit listing news. It has seen a 350% jump in its 24-hour trading volume. The token’s market capitalization has climbed 40% to $198 million. While the broader crypto market sees modest uptick, Bio Protocol (BIO) has witnessed a 40% rally on

In the dynamic landscape of decentralized finance (DeFi), BIO token has ignited a short-term frenzy with its listing on Upbit, one of Asia's leading exchanges.

Upbit, the largest cryptocurrency exchange in South Korea, will list BIO, the token of Bio Protocol, on October 20th. This listing enhances market trust and recognition in Korea, aiming to improve transparency and security in blockchain finance.

Shiba Kusama France developments have got the SHIB Army all worked up, and lead developer Shytoshi Kusama just dropped some cryptic location hints from Europe. Various major community initiatives have been spearheaded when Kuro, a Japanese SHIB Army member, found that Kusama changed his bio on X.

Bio Protocol, a leading DeSci protocol, is set to host Token Generation Events (TGEs) for BiomeAI and eDMT on September 23, 2025, from 20:00 to 21:00 UTC+8, marking a milestone in tokenized biotech innovation. BiomeAI, focused on AI-driven microbiome health trials, achieved 6.4x oversubscription with $3.2M in $BIO pledges, while eDMT, exploring natural DMT production for brain health, hit 4.2x with $1.8M committed. 

Author: Felix, PANews "From $0.1 to $1000, we have come a long way, but this is just the beginning." Binance founder CZ wrote on social media. Following CZ's quiet change of his X account bio from "ex-@binance" back to "@binance", the community erupted, with some shouting "CZ is back", while others expressed feelings of

Bio Protocol (BIO) is currently trading at $0.17 after peaking at $0.326 shortly after its launch on August 23, 2025. A decline in trading volume suggests it has entered an accumulation phase, prompting investor speculation.

Recently, rumors about Binance founder Zhao Changpeng (CZ) possibly making a "heavyweight return" have sparked heated discussions throughout the encryption community. Accompanying this rumor is the unstoppable momentum of Binance's Platform Token BNB - its price broke the $1000 barrier for the first time on September 18, setting a new historical high. The frenzy of the market, the surge in prices, and the political games intertwine, making this event bewildering. Is CZ really returning to Binance? Behind BNB's breakthrough of a thousand yuan, is it merely driven by market sentiment, or is there deeper fundamental support? Rumors of a return are rampant. The catalyst of the event originated from an extremely small detail. Observant community members noticed that Zhao Changpeng (CZ) quietly changed the bio of his personal X (formerly Twitter) account from "ex-@binance" (former BNB member) back to "@binance."

Bio Protocol is a community-driven project designed to provide support to the biotechnology field by combining decentralized science with blockchain infrastructure (DeSci). Its mission is to contribute to early-stage biotechnology projects for everyone involved, primarily researchers, patients, or suppliers.

Today's News Reminder: The Federal Reserve cut interest rates by 25 basis points, and Powell stated that this is a risk management rate cut. The first phase of the TGE for the Binance Aspecta BuildKey model project is River (RIVER). The market value of BNB surpasses that of companies like BYD and Pfizer, rising to 155th place globally. The top 1 address of APX personal holdings, which has been held for three years, gained a floating profit of $3.783 million overnight. BNB broke through $1000, rising 4.97% in 24 hours. Bio Protocol raised $6.9 million in funding, led by Maelstrom Fund. DeFi

Bitcoin , Ethereum , and XRP experienced notable volatility on Friday, rising alongside stocks then reversing momentum as equities also dropped. Although the global crypto market cap hovers around $3.81 trillion, liquidations are up 32% to over $345 million Despite the market sentiment for the t

Bio Protocol (BIO) shows signs of recovery after a significant drop, with key support at $0.15. Despite a recent market downturn, bullish sentiment is emerging with Bitcoin and Ethereum leading the charge, suggesting a potential altseason. Technical indicators favor an upward trend, hinting at a positive outlook for BIO's price recovery in the coming days.

Encryption Market Overview According to CoinGecko data, from August 12 to August 25, 2025, in terms of market trends, BTC continues to be in a descending channel, with weak rebound momentum, but the amount of contract positions remains high, indicating that market sentiment has shifted to a wait-and-see approach. Attention should be paid to key support levels and changes in positions to assess rebound opportunities. ETH, on the other hand, shows strong momentum, once breaking through 4,900 USDT to reach a new high, with funds continuously flowing in and the ETF spot management scale exceeding 30.5 billion USD. If it can hold short-term support, it is expected to continue its upward trend, showing a structure that is significantly stronger than BTC. Recently, the encryption market has shown trends of institutionalization and cross-ecosystem integration. In terms of ecology, BenFen and the Stellar Foundation are advancing RWA on-chain, while Wormhole intends to acquire StarGate.

In the crypto market from August 18 to 25, 2023, the Meme zone performed prominently, especially with DONKEY rising by 270%. At the same time, emerging projects BIO and XTER also rose by 240% and 134%, respectively. Traditional blue-chip assets such as QTUM, AAVE, and ETH showed steady rises, demonstrating structured market characteristics, and users need to follow short-term opportunities and long-term stable asset allocation. Huobi HTX provides a rich array of investment choices and a secure trading environment.

SMX partners with Bio-Packaging to create sustainable packaging featuring molecularly traceable markers, ensuring verified recycling and eco-credentials through a blockchain platform. This collaboration promotes transparency and supports Singapore's zero-waste goals.

Last week's market analysis showed that BTC continued to weaken, and after reaching a historical high, ETH entered a Sideways consolidation. Morpho protocol's TVL exceeded 10 billion, and Bio Protocol's rise approached 200%. With the support of the Fed, ETH saw strong capital inflows, and stablecoin regulation has entered a new phase.

Since the launch of staking, Bio Protocol ($BIO) tokens have experienced a remarkable price increase of over 300%. Data from Pine Analytics shows strong engagement from the community, with daily lock-ups ranging from hundreds of thousands to $9 million. On multiple days, between 20 and 200 wallets c

Triple-digit surges in MAT, XTER, and NEON drive weekly crypto market momentum. Mid-tier tokens like BIO, FLOCK, and MEME show strong participation across categories. Large-cap assets OKB, ONT, and QTUM record solid gains alongside smaller speculative tokens. The latest weekly chart dated

In the past few days, the cryptocurrency market suddenly experienced a "sharp brake." The market, which was originally soaring, suddenly turned downward, causing Bitcoin to lose a key position and altcoins to collectively pull back significantly. What exactly happened? What does this mean behind the scenes? Alts lead the decline, generally falling. Today, most crypto alts have fallen across the board. Data shows that only 14 spot coins on the Binance platform are in an uptrend, while the majority of coins are being pressured down by the market. Projects that performed strongly in the early stage are the first to be affected: •BIO has dropped by 16.84% in the last 24 hours, currently priced at 0.2039 dollars; •CRV fell by 13.89%, current price is 0.7853 dollars; •MEME fell by 12.18%, current price is 0.003464 dollars; •LDO dropped

Longevity research is intersecting with crypto through Aubrai, a decentralized science (DeSci) and AI agent launched this week on Base as part of the Bio Protocol. Decentralized science, or DeSci, uses blockchain and DAOs to fund experiments directly, attribute credit transparently, and turn resear

The Bio Protocol (BIO) token rose 27%, maintaining a 300% monthly surge, fueled by excitement over the Aubrai AI science agent launch and significant whale investments, including $1 million from Arthur Hayes.

Author: Nicky, Foresight News The token BIO of Bio Protocol has recently performed impressively. According to Bitget data, the price of BIO started at $0.056 on August 6, 2025, and soared to a peak of $0.2081 on August 22, with an increase of over 270% during this period. Currently, the staking scale of BIO has reached approximately 174 million coins, accounting for about 9.3% of the total circulation of 1.855 billion coins. At the same time, BIO has been listed on several mainstream exchanges, including

BIO trades at $0.1497, up 2.7% in 24h, after breaking out of its long-term accumulation range. The token holds support at $0.1429 while resistance stands at $0.1725, defining the immediate trading zone. BIO gained 3.0% against BTC and 0.9% against ETH, reflecting strength beyond its USDT

As of the third week of August, many altcoins have recorded a sharp decline in reserve volume on the exchange. This trend reflects the increasing demand for accumulation and holding off the exchange. This is even more noteworthy as the current "altcoin season" has become more selective. So those

Tokens and coins that moved the most in the last 24 hours: ☀️ 9:00 – Morning Pulse: Market Attempts a Tentative Rebound – Top Movers of the Day Bio Protocol and OKB: These cryptocurrencies have been the best performers over the past 24 hours. MX Token has delivered the most substantial

The cryptocurrency market is recovering, with Ethereum rising to $4,300 and Chromia (CHR) gaining 10%. CHR's bullish pattern mirrors Bio Protocol's (BIO) breakout, indicating a potential rally if it surpasses the $0.1083 resistance.

On August 20, the on-chain monitoring platform Ai Yi (@ai_9684xtpa) discovered that legendary trader Arthur Hayes is suspected of significantly building a position of 7.66 million BIO tokens, valued at approximately 1.1 million USD. Since August 10, he has cumulatively invested 14.37 million USD in 6 Ethereum ecosystem tokens, attracting high attention from the market and community.

Bio Protocol funds $80K brain health trial, earning CLAW royalty tokens. Staked BIO tokens rise to 125M, tightening supply and boosting demand. Harmonic chart pattern signals a possible BIO price rally toward $0.1787. The Bio Protocol (BIO) token has regained strong momentum after a sharp

Tokens and coins that moved the most in the last 24 hours: ☀️ 9:00 – Morning Pulse: Market Corrects After Overnight Rally Fails – Top Movers of the Day Bio Protocol and Waves: These cryptocurrencies have been the best performers over the past 24 hours, with Waves delivering the most

Tokens and coins that moved the most in the last 24 hours: ☀️ 9:00 – Morning Pulse: Market Plunges to New Lows – Top Movers of the Day Bio Protocol and Venice Token: These cryptocurrencies have been the best performers over the past 24 hours. Helium has delivered the most substantial

encryption asset panorama BTC (-1.52% | Current Price 115,804 USDT) Previously, BTC once surged to a stage high of 124,497 dollars but failed to break through effectively, followed by a volume-backed pullback. In terms of the moving average system, the short-term MA5 and MA10 have crossed below MA30, forming a bearish arrangement, indicating a weak short-term trend. Recently, the price has repeatedly found support near 115,800 dollars, but it is currently approaching this critical level. If it breaks below this range, it may further test the support at 114,000 dollars or even lower. Conversely, if it can stabilize and rebound at this level, it will first need to reclaim the short-term moving average resistance near 117,300 dollars to reverse the weak trend. In terms of trading volume, a significant increase in volume accompanied by a decline indicates strong selling pressure and a bearish market sentiment. Overall, in the short term, attention should be paid to 115.

The DeSci sector leader BIO, after experiencing a price low, has recently launched version V2, introducing new mechanisms such as Launchpad and stake points. Its market capitalization has quickly rebounded, reigniting the market's attention and expectations for Decentralization in science. (Previous context: Can DeSci address the "broken window effect" in research funding?)

Public companies are accelerating their Solana treasury acquisitions significantly in 2025. Bio-tech leader iSpecimen has announced a major $200 million SOL investment plan this week. This commitment mirrors a wider corporate trend embracing Solana’s digital asset potential Consequently, Solan

According to Foresight News, Bio Protocol has launched phase V2 with Launcher V2, allowing users to sell BioAgent, IP-Token, and BioDAO. Users can stake tokens to earn BioXP and Accumulation points for new sales.

The crypto exchange Coinbase is listing ResearchCoin (RSC) and Bio Protocol (BIO).

In 2025, Bio Protocol implemented key updates to support its role as a decentralized science platform that uses blockchain technology to allow global communities to fund, develop, and govern tokenized scientific intellectual property in biotechnology. The protocol connects patients,

The cryptocurrency world is buzzing with excitement once again as Coinbase, one of the largest and most trusted crypto exchanges globally, makes a significant announcement. Adding new assets to its listing roadmap is always a pivotal moment, signaling potential growth and fresh opportunities for

Coinbase, one of the leading cryptocurrency exchanges, has announced the addition of Bio Protocol (BIO) and Euler (EUL) to its asset listing roadmap

The U.S. listed company Profusa has signed a $100 million equity credit line with Ascent Partners Fund, planning to invest all the funds into Bitcoin, yet the stock price has fallen instead of rising... Why? (Background: MicroStrategy has increased its position by $740 million in Bitcoin, with total holdings approaching 610,000 BTC; MSTR has risen 50% this year) (Additional context: Is MicroStrategy going to sell Bitcoin? CryptoQuant warns: New accounting and tax regulations force Strategy to exit and pay taxes) The U.S. listed company Profusa (NASDAQ: PFSA), focused on the development of bio-integrated sensors, announced on the 21st that it has signed a $100 million equity credit line with Ascent Partners Fund LLC.

Parataxis launches Korea's first BTC treasury firm by acquiring Bridge Bio, marking a significant step in corporate crypto adoption in Asia, inspired by MicroStrategy and joining the ranks of Bitcoin-heavy companies.

Bitcoin investment company Parataxis Holdings has reached a 25 billion KRW investment agreement with Bridge Biotherapeutics to acquire a controlling stake and rename it Parataxis Korea. After the transaction, a Bitcoin-based fund management platform will be created, with Edward Chin and Andrew Kim joining the board, while James Jungkue Lee continues to lead the biotech business.

Bio Protocol announces the approval of the BIOPSY-22 proposal, whereby the core team's $BIO-year Cliff unlock (originally scheduled for 5/28/2025) will be released linearly for six months starting November 14 this year. This move aims to synchronize the token release with the development of the ecosystem, reduce the initial market volatility, and demonstrate the team's commitment and responsible attitude towards the long-term development of the project. (Synopsis: Bio Protocol Launches V1 Upgrade!) Take the DeSci wave to make up for the shortfall in traditional scientific research funding) (Background supplement: BIO listed Binance market value exceeded 2.4 billion magnesium, the first batch to enter the market to earn 57 times! What is the potential of the DeSci field? This article is widely compiled, written and provided by Bio Protocol, and does not represent the position of the region and is not investment advice, purchase or sale advice. For details, please refer to the liability warning at the end of the article.